Both in Pharmaceuticals
Nuvation Bio vs Kailera Therapeutics
Over the past year NUVB returned −22.1% and KLRA returned −8.2%; their daily moves had a correlation of 0.33.
NUVB −22.1% KLRA −8.2%Growth of $1, one year, split-adjusted
| Metric | NUVB | KLRA |
|---|---|---|
| Price | $4.73 | $12.80 |
| Market cap | $1.66B | $1.66B |
| Today | +0.85% | +1.75% |
| 1 month | −3.1% | +18.2% |
| 6 months | −6.2% | — |
| Year to date | −47.2% | — |
| 1 year | −8.5% | — |
| Revenue growth (YoY) | +555.6% | — |
| Gross margin | 73.0% | — |
| Net margin | −198.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 9.8× | — |
| Net cash | $399.4M | $916.7M |
| Dividend yield | — | — |
| Volatility (60d) | 50.8% | — |
| Short % of float | 23.9% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).